MyAverix Finance
SA · Healthcare
Takeda Pharmaceutical Company Limited (TAKP34)
Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Company Limited (TAKP34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $301.07B, P/E ratio is 82.16, net margin is 2.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TAKP34
Takeda Pharmaceutical Company Limited (TAKP34) — FAQ
What is Takeda Pharmaceutical Company Limited's market cap?
Takeda Pharmaceutical Company Limited (TAKP34) has a reported market cap of $301.07B (data as of 2026-03-29).
What is TAKP34's P/E ratio?
The price-to-earnings (P/E) ratio for Takeda Pharmaceutical Company Limited (TAKP34) is 82.16 (data as of 2026-03-29).
Does Takeda Pharmaceutical Company Limited pay a dividend?
Dividend yield is not available in the current snapshot for Takeda Pharmaceutical Company Limited (TAKP34). Check the MyAverix Finance app for the latest dividend data.
What sector is Takeda Pharmaceutical Company Limited in?
Takeda Pharmaceutical Company Limited (TAKP34) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is TAKP34 listed on?
TAKP34 is listed on SA.
What is Takeda Pharmaceutical Company Limited's net margin?
Takeda Pharmaceutical Company Limited (TAKP34) reports a net margin of 2.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.